COST-EFFECTIVENESS OF HLA-B*1502 GENOTYPING IN ADULT PATIENTS WITH NEWLY DIAGNOSED EPILEPSY IN SINGAPORE

被引：5
|
作者：
Hung, Shuen-Iu
Chung, Wen-Hung
机构：
来源：
NEUROLOGY | 2013年 / 80卷 / 17期
关键词：
D O I：
10.1212/WNL.0b013e3182915be2
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1621 / 1621
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of HLA-B*1502 genotyping in adult patients with newly diagnosed epilepsy in Singapore
    Dong, Di
    Sung, Cynthia
    Finkelstein, Eric Andrew
    [J]. NEUROLOGY, 2012, 79 (12) : 1259 - 1267
  • [2] Cost-effectiveness of screening for HLA-B*1502 prior to initiation of carbamazepine in epilepsy patients of Asian ancestry in the United States
    Choi, Hyunmi
    Mohit, Babak
    [J]. EPILEPSIA, 2019, 60 (07) : 1472 - 1481
  • [3] Cost-effectiveness analysis of genotyping for HLA-B*15:02 in Indonesian patients with epilepsy using a generic model
    Yuliwulandari, Rika
    Shin, Jae Gook
    Kristin, Erna
    Suyatna, Fransiscus D.
    Prahasto, Iwan Dwi
    Prayuni, Kinasih
    Mahasirimongkol, Surakameth
    Cavallari, Larisa H.
    Mitropoulou, Christina
    Patrinos, George P.
    Hao, Jing
    Williams, Marc S.
    Snyder, Susan R.
    [J]. PHARMACOGENOMICS JOURNAL, 2021, 21 (04): : 476 - 483
  • [4] Cost-effectiveness analysis of genotyping for HLA-B*15:02 in Indonesian patients with epilepsy using a generic model
    Rika Yuliwulandari
    Jae Gook Shin
    Erna Kristin
    Fransiscus D. Suyatna
    Iwan Dwi Prahasto
    Kinasih Prayuni
    Surakameth Mahasirimongkol
    Larisa H. Cavallari
    Christina Mitropoulou
    George P. Patrinos
    Jing Hao
    Marc S. Williams
    Susan R. Snyder
    [J]. The Pharmacogenomics Journal, 2021, 21 : 476 - 483
  • [5] Cost-effectiveness analysis of genotyping for HLA-B*5801 and an enhanced safety program in gout patients starting allopurinol in Singapore
    Dong, Di
    Tan-Koi, Wei-Chuen
    Teng, Gim Gee
    Finkelstein, Eric
    Sung, Cynthia
    [J]. PHARMACOGENOMICS, 2015, 16 (16) : 1781 - 1793
  • [6] HLA-B*5701 Genotyping for Abacavir Prescription: Re-Examination of its Cost-Effectiveness in Singapore
    Goh, Kang Shiong
    Kapoor, Ritika
    Lee, Cheng Chuan
    Ng, Carol Y. L.
    Leong, Khai Pang
    [J]. ANNALS ACADEMY OF MEDICINE SINGAPORE, 2019, 48 (04) : 133 - 138
  • [7] COST-EFFECTIVENESS OF ROUTINE TESTING FOR HLA-B*5801 IN CAUCASIAN PATIENTS NEWLY DIAGNOSED WITH GOUT IN PORTUGUESE NHS HOSPITALS
    Araujo, M.
    Pinto, C. G.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A379 - A379
  • [8] Cost-effectiveness analysis of HLA-B*15:02 screening before treatment of epilepsy in Indonesia
    Tanoto, Eric
    Khosama, Herlyani
    Jehosua, Seilly
    Sekeon, Sekplin A. S.
    Karema, Winifred
    Mawuntu, Arthur H. P.
    Langi, Fima F. L. G.
    Seang, Lim Kheng
    [J]. EPILEPSY & BEHAVIOR, 2024, 155
  • [9] A cost-effectiveness decision model for antiepileptic drug treatment in newly diagnosed epilepsy patients
    Knoester, Pieter D.
    Deckers, Charles L. P.
    Termeer, Eveline H.
    Boendermaker, Arjo J.
    Kotsopoulos, Irene A. W.
    de Krom, Marc C. T. F. M.
    Keyser, Toine
    Renier, Willy O.
    Hekster, Yechiel A.
    Severens, Hans L.
    [J]. VALUE IN HEALTH, 2007, 10 (03) : 173 - 182
  • [10] Cost-effectiveness of HLA-B*15:02 screening in Malaysia
    Plumpton, C.
    Hughes, D.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (04) : 904 - 905
12345